| Schedule of basic and diluted net income (loss) per share |
Basic and diluted net income (loss) per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net Income (loss) |
$ |
5,999 |
|
$ |
(18,615) |
|
$ |
(89,364) |
|
$ |
(58,102) |
| Reallocation of net income attributable to participating securities |
(74) |
|
— |
|
— |
|
— |
| Net income (loss) attributable to common stockholders – basic and diluted |
$ |
5,925 |
|
$ |
(18,615) |
|
$ |
(89,364) |
|
$ |
(58,102) |
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted average common shares outstanding – basic |
150,206,893 |
|
144,117,273 |
|
148,521,299 |
|
143,522,555 |
| Weighted average effect of potentially dilutive securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options |
16,528,407 |
|
— |
|
— |
|
— |
| Restricted stock units |
6,674,985 |
|
— |
|
— |
|
— |
| Performance stock units |
356,780 |
|
— |
|
— |
|
— |
| Finback Common Stock Warrants |
209,310 |
|
— |
|
— |
|
— |
| Total potentially dilutive securities |
23,769,482 |
|
— |
|
— |
|
— |
| Weighted average common shares outstanding — diluted |
173,976,375 |
|
144,117,273 |
|
148,521,299 |
|
143,522,555 |
| Net income (loss) per share attributable to common stockholders - basic |
$ |
0.04 |
|
$ |
(0.13) |
|
$ |
(0.60) |
|
$ |
(0.40) |
| Net income (loss) per share attributable to common stockholders - diluted |
$ |
0.03 |
|
$ |
(0.13) |
|
$ |
(0.60) |
|
$ |
(0.40) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of potential common shares excluded from the computation of diluted net loss per share |
The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
Nine Months Ended
September 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Options issued and outstanding |
— |
|
|
21,027,840 |
|
|
21,063,044 |
|
21,027,840 |
|
| Public Warrants to purchase common stock |
14,324,893 |
|
|
14,324,994 |
|
|
14,324,893 |
|
|
14,324,994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase common stock (Finback)** |
1,317,327 |
|
|
2,421,200 |
|
|
1,590,984 |
|
|
2,421,200 |
|
| Unvested restricted stock units |
397,771 |
|
|
7,336,179 |
|
|
12,097,108 |
|
|
7,336,179 |
|
| Unvested performance stock units |
— |
|
|
889,000 |
|
|
386,000 |
|
|
889,000 |
|
| Earn-out shares* |
15,000,000 |
|
|
15,000,000 |
|
|
15,000,000 |
|
|
15,000,000 |
|
| Contingently issuable common stock* |
1,897,500 |
|
|
1,897,500 |
|
|
1,897,500 |
|
|
1,897,500 |
|
|
|
|
|
|
|
|
|
|
32,937,491 |
|
|
62,896,713 |
|
|
66,359,529 |
|
|
62,896,713 |
|
*Issuance of Earn-out shares and Contingently issuable common stock is contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period
**Includes 273,657 vested warrants and 1,317,327 unvested warrants as of September 30, 2023
|